Announcement on Obtaining Approval for Production of Tofacitinib Citrate Sustained-Release Tablets
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference:
Filed with SSE · · 2 pages · Chinese
Shanghai Pharmaceuticals Holding Co. Ltd. has announced that its subsidiary has received approval for the production of Tofacitinib Citrate Sustained-Release Tablets from the National Medical Products Administration.
Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries
Announcement on Obtaining Approval for Production of Tofacitinib Citrate Sustained-Release Tablets
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference:
Shanghai Pharmaceuticals Holding Co. Ltd. on 6ix
Follow Shanghai Pharmaceuticals into a list and get an email when it puts out news.
Follow Shanghai Pharmaceuticals